Imricor Medical Systems, Inc. (IMR.AX)
AUD 1.19
(-8.46%)
AUD 1.19
(-8.46%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -21.87 Million AUD | -46.35% |
| 2022 | -16.46 Million USD | 13.04% |
| 2021 | -18.93 Million AUD | -62.98% |
| 2020 | -11.61 Million AUD | 3.23% |
| 2019 | -12 Million AUD | -89.13% |
| 2018 | -6.12 Million AUD | 1.01% |
| 2017 | -6.41 Million AUD | -20.94% |
| 2016 | -5.3 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -3.84 Million USD | -4.21% |
| 2024 Q2 | -3.84 Million USD | 0.0% |
| 2023 Q1 | -4.38 Million USD | -22.13% |
| 2023 FY | - AUD | -46.35% |
| 2023 Q4 | -3.69 Million USD | 0.0% |
| 2023 Q3 | -3.69 Million USD | 15.81% |
| 2023 Q2 | -4.38 Million USD | 0.0% |
| 2022 FY | - USD | 13.04% |
| 2022 Q3 | -3.58 Million USD | 23.38% |
| 2022 Q2 | -4.68 Million USD | -0.0% |
| 2022 Q1 | -4.68 Million USD | 7.69% |
| 2022 Q4 | -3.58 Million USD | 0.0% |
| 2021 Q3 | -5.07 Million USD | -7.74% |
| 2021 Q4 | -5.07 Million USD | 0.0% |
| 2021 Q2 | -4.71 Million USD | 0.0% |
| 2021 FY | - AUD | -62.98% |
| 2021 Q1 | -4.71 Million USD | -49.66% |
| 2020 Q1 | -2.56 Million USD | -53.8% |
| 2020 Q3 | -3.14 Million USD | -22.62% |
| 2020 Q2 | -2.56 Million USD | 0.0% |
| 2020 Q4 | -3.14 Million USD | 0.0% |
| 2020 FY | - AUD | 3.23% |
| 2019 Q1 | -1.47 Million USD | -15.53% |
| 2019 FY | - AUD | -89.13% |
| 2019 Q4 | -1.66 Million USD | 0.0% |
| 2019 Q3 | -1.66 Million USD | -13.06% |
| 2019 Q2 | -1.47 Million USD | 0.0% |
| 2018 Q3 | -1.27 Million USD | -17.0% |
| 2018 Q1 | -1.09 Million USD | 0.0% |
| 2018 Q2 | -1.09 Million USD | 0.0% |
| 2018 Q4 | -1.27 Million USD | 0.0% |
| 2018 FY | - AUD | 1.01% |
| 2017 FY | - AUD | -20.94% |
| 2016 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 39.361% |
| Adherium Limited | -11.56 Million AUD | -89.117% |
| Aroa Biosurgery Limited | -7.36 Million AUD | -197.149% |
| Atomo Diagnostics Limited | -5.42 Million AUD | -303.253% |
| Anteris Technologies Ltd | -66.9 Million AUD | 67.311% |
| Control Bionics Limited | -5.15 Million AUD | -323.993% |
| CardieX Limited | -6.71 Million AUD | -225.848% |
| Compumedics Limited | 2.78 Million AUD | 884.167% |
| Cochlear Limited | 579.5 Million AUD | 103.774% |
| CleanSpace Holdings Limited | -3.49 Million AUD | -526.336% |
| Cyclopharm Limited | -3.03 Million AUD | -620.63% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | -945.827% |
| Nova Eye Medical Limited | -5.97 Million AUD | -265.787% |
| HeraMED Limited | -3.97 Million AUD | -450.606% |
| ImpediMed Limited | -22.05 Million AUD | 0.819% |
| InhaleRx Limited | -1.41 Million AUD | -1446.986% |
| LBT Innovations Limited | -4.04 Million AUD | -440.143% |
| Micro-X Limited | -14.35 Million AUD | -52.396% |
| Neurotech International Limited | -8.24 Million AUD | -165.288% |
| OncoSil Medical Limited | -11.97 Million AUD | -82.616% |
| PolyNovo Limited | 5.17 Million AUD | 523.025% |
| Respiri Limited | -7.04 Million AUD | -210.223% |
| SomnoMed Limited | -2.32 Million AUD | -839.203% |
| Universal Biosensors, Inc. | -9.09 Million AUD | -140.587% |
| Uscom Limited | -1.5 Million AUD | -1349.034% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | -344.756% |